» Articles » PMID: 30483483

Cellular Targets for the Treatment of Flavivirus Infections

Overview
Date 2018 Nov 29
PMID 30483483
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Classical antiviral therapy targets viral functions, mostly viral enzymes or receptors. Successful examples include precursor herpesvirus drugs, antiretroviral drugs that target reverse transcriptase and protease, influenza virus directed compounds as well as more recent direct antiviral agents (DAA) applied in the treatment of hepatitis C virus (HCV). However, from early times, the possibility of targeting the host cell to contain the infection has frequently re-emerged as an alternative and complementary antiviral strategy. Advantages of this approach include an increased threshold to the emergence of resistance and the possibility to target multiple viruses. Major pitfalls are related to important cellular side effects and cytotoxicity. In this mini-review, the concept of host directed antiviral therapy will be discussed with a focus on the most recent advances in the field of Flaviviruses, a family of important human pathogens for which we do not have antivirals available in the clinics.

Citing Articles

A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection.

Tripathi A, Chauhan S, Khasa R Viruses. 2025; 17(1).

PMID: 39861863 PMC: 11769230. DOI: 10.3390/v17010074.


Japanese encephlu emergence in Australia: the potential population at risk.

Khan A, Riaz R, Nadeem A, Amir A, Siddiqui T, Batool U Ann Med Surg (Lond). 2024; 86(3):1540-1549.

PMID: 38463109 PMC: 10923274. DOI: 10.1097/MS9.0000000000001739.


Microtubule disruption synergizes with STING signaling to show potent and broad-spectrum antiviral activity.

Han J, Wang Z, Han F, Peng B, Du J, Zhang C PLoS Pathog. 2024; 20(2):e1012048.

PMID: 38408104 PMC: 10919859. DOI: 10.1371/journal.ppat.1012048.


Current Advances in Japanese Encephalitis Virus Drug Development.

Guo J, Mi Y, Guo Y, Bai Y, Wang M, Wang W Viruses. 2024; 16(2).

PMID: 38399978 PMC: 10892782. DOI: 10.3390/v16020202.


Dengue virus exploits the host tRNA epitranscriptome to promote viral replication.

Chan C, Sze N, Suzuki Y, Ohira T, Suzuki T, Begley T bioRxiv. 2023; .

PMID: 37986976 PMC: 10659268. DOI: 10.1101/2023.11.05.565734.


References
1.
Campos R, Wong B, Xie X, Lu Y, Shi P, Pompon J . RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation. J Virol. 2016; 91(4). PMC: 5286887. DOI: 10.1128/JVI.01706-16. View

2.
Sessions O, Barrows N, Souza-Neto J, Robinson T, Hershey C, Rodgers M . Discovery of insect and human dengue virus host factors. Nature. 2009; 458(7241):1047-50. PMC: 3462662. DOI: 10.1038/nature07967. View

3.
Li M, Grandadam M, Kwok K, Lagache T, Siu Y, Zhang J . KDEL Receptors Assist Dengue Virus Exit from the Endoplasmic Reticulum. Cell Rep. 2015; 10(9):1496-1507. DOI: 10.1016/j.celrep.2015.02.021. View

4.
Pawlotsky J, Feld J, Zeuzem S, Hoofnagle J . From non-A, non-B hepatitis to hepatitis C virus cure. J Hepatol. 2015; 62(1 Suppl):S87-99. DOI: 10.1016/j.jhep.2015.02.006. View

5.
Kaufmann B, Rossmann M . Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes Infect. 2010; 13(1):1-9. PMC: 3014442. DOI: 10.1016/j.micinf.2010.09.005. View